Levetiracetam in bipolar spectrum disorders: first evidence of efficacy in an open, add- on study.
Bersani
Giuseppe
G
D018692:Antimanic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001569:Benzodiazepines / Q000008:administration & dosage / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D000077287:Levetiracetam; D008297:Male; D010865:Pilot Projects; D010889:Piracetam / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D018692:Antimanic Agents; D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077287:Levetiracetam; D010889:Piracetam